Fate Therapeutics, Inc.

FATE ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
10-Q May 13, 2026 10-Q
8-K May 13, 2026 8-K
4 May 7, 2026 4
4 May 6, 2026 4
4 May 6, 2026 4
ARS Apr 24, 2026 ARS
DEFA14A Apr 24, 2026 DEFA14A
DEF 14A Apr 24, 2026 DEF 14A
4/A Apr 23, 2026 OWNERSHIP DOCUMENT
4 Apr 22, 2026 OWNERSHIP DOCUMENT
SCHEDULE 13D/A Apr 22, 2026
SCHEDULE 13G/A Mar 26, 2026
10-K Feb 26, 2026 10-K
8-K Feb 26, 2026 8-K
4 Jan 16, 2026 4
4 Jan 16, 2026 4
4 Jan 16, 2026 4
4 Jan 12, 2026 4
4 Jan 12, 2026 4
144 Jan 9, 2026
144 Jan 9, 2026
144 Dec 29, 2025
10-Q Nov 13, 2025 10-Q
8-K Nov 13, 2025 8-K
8-K Oct 27, 2025 8-K
← Newer Page 2 of 34 · 848 filings Older →